咖啡因和咖啡的酸在肝脏疾病中的保护作用
Daniela Di Pietrantonio1, Valeria Pace Palitti2, Angelo Cichelli1
1Department of Innovative Technologies in Medicine and Dentistry, "G. d'Annunzio" University, Via dei Vestini 31, 66100 Chieti, Italy.
Foods (Basel, Switzerland)
|July 27, 2024
概括
适度饮用咖啡,富含咖啡因和酸,为肝脏健康提供保护性益处. 这种饮料可能会降低慢性肝病的风险,包括非酒精性脂肪肝炎和肝癌.
科学领域:
- * 药理学和胃肠道学
- * 疾病进展和预防的分子机制.
背景情况:
- * 咖啡是全球流行的饮料,以其香味和咖啡因含量而闻名.
- * 适度咖啡摄入量 (每天3-4杯) 与健康益处有关,包括对代谢疾病的保护.
- * 慢性肝病包括非酒精性脂肪肝炎,病毒性肝炎,肝硬化和肝癌.
研究的目的:
- * 审查咖啡中生物活性化合物咖啡因和酸对慢性肝病进展的影响.
- * 分析咖啡对肝脏的保护作用背后的药理作用和分子机制.
主要方法:
- * 文献综述侧重于实验证据和分子机制.
- *分析研究研究咖啡因和酸在肝病的背景下.
主要成果:
- * 咖啡消费与非酒精性脂肪肝炎,病毒性肝炎,肝硬化和肝细胞癌的风险降低相关.
- * 咖啡因和基酸对肝细胞具有抗纤维作用.
- * 这些化合物降低结缔组织生长因子,促进细胞亡,并抑制纤维化和癌症进展中的关键蛋白质.
结论:
- * 咖啡消费对患有慢性肝病的人来说具有显著的潜在益处.
- *生物活性化合物咖啡因和酸在咖啡的保护作用中起着关键作用.
- *需要进一步的前性研究来证实咖啡在肝脏疾病管理中的预防和治疗作用.
更多相关视频
06:12Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
11.3K
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
848
相关概念视频
Factors Influencing Drug Absorption: Disease States and Pharmacology
481
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
481
Overview of Carbohydrate Metabolism
845
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
845
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
